Should I discontinue the 200 mg trazodone I’m taking for depression, start duloxetine (Cymbalta) for depression, and use a low dose of trazodone for insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommendation for Transitioning from High-Dose Trazodone to Duloxetine for Depression

Yes, you should reduce trazodone to a low dose (50-100 mg) for sleep and start duloxetine (Cymbalta) for depression, as trazodone at 200 mg has insufficient evidence for treating depression and is not FDA-approved for this indication.

Rationale for This Approach

Trazodone's Limited Role in Depression Treatment

The most recent American Academy of Sleep Medicine guideline (2017) explicitly recommends against using trazodone as a treatment for depression 1. A single study of trazodone 50 mg showed no clinically significant improvements in depressive symptoms, and the evidence quality was only moderate 1. Importantly, trazodone is not FDA-approved for insomnia and its efficacy for depression is not well established 2.

Multiple clinical practice guidelines consistently place trazodone as a third-line option for insomnia—only after benzodiazepine receptor agonists fail and specifically when treating comorbid depression/anxiety 2. The 2020 VA/DoD guideline advises against trazodone for chronic insomnia due to low-quality evidence and adverse effects outweighing benefits 3.

Duloxetine as First-Line for Depression

Duloxetine is a well-established first-line treatment for major depressive disorder 4, 5. It has shown consistent efficacy in treating depression with a straightforward dosing regimen 4. The FDA label confirms duloxetine's approval for major depressive disorder 6.

Key dosing strategy: Start duloxetine at 30 mg once daily for 1 week, then increase to 60 mg once daily 4. This gradual titration reduces nausea, the most common side effect 4. Research confirms that lower starting doses with slower titration significantly improve tolerability—discontinuation rates were only 3.6% with gradual titration versus 15% with rapid titration 7.

Specific Implementation Algorithm

Step 1: Initiate Duloxetine

  • Start duloxetine 30 mg once daily in the morning
  • After 7 days, increase to 60 mg once daily
  • Monitor for nausea (most common side effect), which typically resolves after the first week 4
  • Screen for bipolar disorder history before starting (detailed psychiatric and family history of mania, bipolar disorder, suicide) 6

Step 2: Reduce Trazodone Simultaneously

  • Reduce trazodone from 200 mg to 50-100 mg at bedtime for sleep only
  • This lower dose range is what's actually studied for insomnia 1
  • Do not abruptly discontinue—taper gradually to avoid withdrawal symptoms 2
  • The 2008 guideline notes "moderate efficacy for trazodone in improving sleep quality and/or duration" at these lower doses 2

Step 3: Monitor Specific Outcomes

  • For depression: Assess mood, energy, concentration at 2-4 weeks; full therapeutic trial requires 4-8 weeks 4
  • For sleep: Evaluate sleep quality, latency, and total sleep time weekly
  • For safety: Check blood pressure before starting duloxetine and periodically thereafter 6; monitor liver function if risk factors present 6

Critical Safety Considerations

Duloxetine-Specific Warnings

  • Hepatotoxicity: Avoid in patients with substantial alcohol use or chronic liver disease 6
  • Blood pressure: Can increase systolic BP by 0.5 mmHg and diastolic by 0.8 mmHg 6
  • Orthostatic hypotension: Risk increases when combined with antihypertensives or CYP1A2 inhibitors 6
  • Bleeding risk: Use caution with NSAIDs, aspirin, or anticoagulants 6

Trazodone at Lower Doses

  • At 50 mg, trazodone showed headache (30%) and somnolence (23%) as main side effects 1
  • Monitor for daytime sedation, especially when combined with duloxetine 2
  • Avoid in patients with cardiac conduction abnormalities 8

Drug Interaction Alert

Recent research shows that duloxetine significantly affects trazodone concentrations 9. When these medications are combined, trazodone levels may increase, necessitating closer monitoring for excessive sedation or other adverse effects. This supports using the lowest effective trazodone dose (50 mg) when combining with duloxetine.

Why Not Continue High-Dose Trazodone?

The evidence is clear: 200 mg trazodone for depression lacks supporting data. The 2017 AASM guideline found that even 50 mg trazodone failed to produce clinically significant improvements in any sleep or mood outcome variables 1. Higher doses simply increase side effect burden without proven benefit for depression 3, 10.

Alternative Consideration

If insomnia persists despite low-dose trazodone, consider first-line insomnia treatments such as short-intermediate acting benzodiazepine receptor agonists (zolpidem, eszopiclone) or cognitive behavioral therapy for insomnia (CBT-I), which has the strongest evidence base 2. The 2008 guideline notes that combining a benzodiazepine receptor agonist with a sedating antidepressant is supported by "a wealth of clinical experience" 2.

Common Pitfall to Avoid

Do not maintain trazodone at 200 mg while adding duloxetine. This exposes you to:

  • Excessive sedation from drug interaction 9
  • Continued use of an ineffective depression treatment 1
  • Increased risk of serotonin syndrome (though rare) 6
  • Higher adverse effect burden without therapeutic benefit 3

References

Guideline

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Related Questions

What is the maximum recommended daily dose of trazodone for an adult?
Can a generally healthy patient safely use trazodone (25–100 mg at bedtime, up to 400 mg) together with loperamide (Imodium) (2 mg after each loose stool, max 8 mg/day) without increased risk of constipation or bowel obstruction?
An 11-year-old with mood dysregulation, anxiety, and insomnia is currently taking trazodone 3 mg and oxcarbazepine 600 mg daily; what medication adjustments and management strategies are recommended?
Is it safe for a patient taking sertraline 50 mg daily for depression to add low‑dose trazodone for insomnia?
At what dose of trazodone do adverse effects begin to be reported?
How can insulin therapy be optimized in a patient with diabetes who is on a basal‑bolus regimen and empagliflozin (Jardiance)?
In an adult with a confirmed Staphylococcus aureus infection, what are the appropriate antibiotic regimens for methicillin‑susceptible Staphylococcus aureus (MSSA) versus methicillin‑resistant Staphylococcus aureus (MRSA)?
What is the recommended treatment for middle insomnia (sleep maintenance insomnia)?
What is the first‑line antibiotic regimen for Streptococcus pneumoniae and aspiration pneumonia in an adult?
Which vascular territory supplies the right eye and would be implicated in right‑sided eye pain?
Are ceftriaxone and clarithromycin appropriate empiric treatment for community-acquired pneumonia caused by Streptococcus pneumoniae in an adult patient without known drug allergies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.